Evidence map›Paper›PMID 24349203›Full record

ArticlePloS one2013

Skeletal cell differentiation is enhanced by atmospheric dielectric barrier discharge plasma treatment.

Marla J Steinbeck, Natalie Chernets, Jun Zhang, Deepa S Kurpad, Gregory Fridman, Alexander Fridman, Theresa A Freeman

Abstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marla J SteinbeckDepartment of Biomedical Engineering, Drexel University, Philadelphia, Pennsylvania, United States of America.
Natalie ChernetsDepartment of Electrical Engineering, Drexel University, Philadelphia, Pennsylvania, United States of America.
Jun ZhangDepartment of Orthopaedics, The Second Hospital of Jilin University, Chang Chun, Jilin, China ; Department of Orthopaedic Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America.
Deepa S KurpadDepartment of Orthopaedic Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America.
Gregory FridmanDepartment of Biomedical Engineering, Drexel University, Philadelphia, Pennsylvania, United States of America.
Alexander FridmanDepartment of Mechanical Engineering and Mechanics, Drexel University, Philadelphia, Pennsylvania, United States of America.
Theresa A FreemanDepartment of Orthopaedic Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America.

Funding

Non-Thermal Plasma in Biomedicine: A New Paradigm for Redox Cell ActivationR01EB013011 · NIBIB · THOMAS JEFFERSON UNIVERSITY · PI FREEMAN, THERESA A · 2011 to 2014
$1.4M
ROS activation of Apoptosis Signal-regulated Kinase1 (Ask1) in chondrocytesR03DE020840 · NIDCR · THOMAS JEFFERSON UNIVERSITY · PI FREEMAN, THERESA A · 2010 to 2011
$232k
NIBIB NIH HHS 1 R01 EB 013011-01NIBIB NIH HHS R01 EB013011NIDCR NIH HHS 5R03 DE020840-03NIDCR NIH HHS R03 DE020840
6 · The paper itself

Abstract

Enhancing chondrogenic and osteogenic differentiation is of paramount importance in providing effective regenerative therapies and improving the rate of fracture healing. This study investigated the potential of non-thermal atmospheric dielectric barrier discharge plasma (NT-plasma) to enhance chondrocyte and osteoblast proliferation and differentiation. Although the exact mechanism by which NT-plasma interacts with cells is undefined, it is known that during treatment the atmosphere is ionized generating extracellular reactive oxygen and nitrogen species (ROS and RNS) and an electric field. Appropriate NT-plasma conditions were determined using lactate-dehydrogenase release, flow cytometric live/dead assay, flow cytometric cell cycle analysis, and Western blots to evaluate DNA damage and mitochondrial integrity. We observed that specific NT-plasma conditions were required to prevent cell death, and that loss of pre-osteoblastic cell viability was dependent on intracellular ROS and RNS production. To further investigate the involvement of intracellular ROS, fluorescent intracellular dyes Mitosox (superoxide) and dihydrorhodamine (peroxide) were used to assess onset and duration after NT-plasma treatment. Both intracellular superoxide and peroxide were found to increase immediately post NT-plasma treatment. These increases were sustained for one hour but returned to control levels by 24 hr. Using the same treatment conditions, osteogenic differentiation by NT-plasma was assessed and compared to peroxide or osteogenic media containing β-glycerolphosphate. Although both NT-plasma and peroxide induced differentiation-specific gene expression, neither was as effective as the osteogenic media. However, treatment of cells with NT-plasma after 24 hr in osteogenic or chondrogenic media significantly enhanced differentiation as compared to differentiation media alone. The results of this study show that NT-plasma can selectively initiate and amplify ROS signaling to enhance differentiation, and suggest this technology could be used to enhance bone fusion and improve healing after skeletal injury.

Indexed as

ElectricityAnimalsAtmosphereCell DeathCell DifferentiationCell LineCell ProliferationChondrocytesIntracellular SpaceMiceOsteoblastsOsteogenesisPlasma GasesPolymerase Chain ReactionReactive Oxygen SpeciesPlasma GasesReactive Oxygen Species

Identifiers

PMID24349203
PMCPMC3861356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.